Arena ADVISE - Home

Stop hidingfrom your moderate-to-severe eczema

The ADVISE Study is evaluating the safety and effectiveness of an investigational medication, taken orally, designed for moderate-to-severe eczema.

Let’s work together to find a potential new treatment for this frustrating condition.

You may be able to take part in the ADVISE Study if:

You will receive all study-related care at no cost. Health insurance is not needed.

About Eczema

Eczema is a term used to describe medical conditions that cause red, inflamed, and itchy skin.


0 Million

adults have some form of moderate-to-severe atopic dermatitis in the United States.

It is more common in females than males

The most common form of eczema, atopic dermatitis, is caused by a malfunction in the immune system

The annual economic burden of moderate-to-severe eczema in the United States is estimated at $5.3 billion

In order to improve the quality of life in those with moderate-to-severe eczema, more research is sorely needed.


If moderate-to-severe eczema is something you struggle with, consider joining the ADVISE Study now

Your choice regarding cookies on this site

We use cookies to optimize site functionality and give you the best experience. Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.

For more detailed information on the cookies we use, please check our Privacy Policy.

By continuing to access this website you are giving us consent to collect cookies.